Research institute
Pherecydes Pharma and BIOASTER, the French Technology Research Institute for Microbiology and Infectious Diseases, announce the signing of a collaboration agreement.
Multiple sclerosis (MS) is an often-disabling disease of the central nervous system caused by damage to the myelin coating around the nerves.
Blocking IL-6 pathway may extend duration of immunotherapy and reduce side effects
MIT’s Research Enterprise in Singapore, SMART, launches a new research group, Critical Analytics for Manufacturing Personalized-Medicine (CAMP), as part of Singapore’s National Cell Manufacturing Initiative to overcome scientific and technical challenges in life-changing cell therapies.
Targeted drugs for breast and lung cancer could be used together to overcome resistance to treatment in several different tumour types, a new study shows.
A recent study found that combining a well-known breast cancer drug with a lung cancer drug, at least in cells in the laboratory, was significantly more effective in killing cancer cells.
The companies indicate they hope to continue data analysis to better understand the disease and will present anything relevant at a future scientific meeting.
The National Institute of Health Research has announced £135m of funding for new research projects across the UK to tackle some of the biggest health conditions, including dementia.
Novotech, the award-winning Asia-Pacific CRO, has further strengthened its presence in the region through a Partnership with the Skin Research Institute of Singapore.
Three national research groups and a leading health technology company are teaming together to discover the frailty biomarkers that may shed light on why some people become frail, determine the severity of frailty and what can be done to help avoid the condition.
PRESS RELEASES